PROTEINFORMULIERUNGEN

European patent · EP3160511 · In force

Register entry

Publication number
EP3160511
Application number
EP15738505
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 15, 2015
Published
May 3, 2017
Granted
Jul 26, 2023
Protection ends at the latest
Jun 14, 2035
Next annual fee due
Jun 30, 2027
IPC classes
A61K 38/18 (2006.01)
A61K 47/20 (2006.01)
A61P 7/06 (2006.01)
A61P 37/02 (2006.01)
A61K 47/26 (2006.01)
A61K 9/19 (2006.01)
A61K 47/18 (2017.01)
Priority
US 201462017560 P 26.06.2014
PCT application
PCT/US2015/035884 15.06.2015
PCT publication
WO2015/200027 30.12.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jun 5, 2024

    Change

    Published in Swissreg on 05.06.2024

  5. Jul 26, 2023

    Granted

    Published in Swissreg on 26.07.2023

Parties

Holder

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Inventor

MCAULEY, Arnold J.

Moorpark, California 93021, US

PARK, Sungae

Thousand Oaks, California 91320, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.